BH4 activates CaMKK2 and rescues the cardiomyopathic phenotype in rodent models of diabetes
Authors:
Open Access
- 22 July 2020
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 3 (9) , e201900619
Abstract
Diabetic cardiomyopathy (DCM) is a major cause of mortality/morbidity in diabetes mellitus patients. Although tetrahydrobiopterin (BH4) shows therapeutic potential as an endogenous cardiovascular target, its effect on myocardial cells and mitochondria in DCM and the underlying mechanisms remain unknown. Here, we determined the involvement of BH4 deficiency in DCM and the therapeutic potential of BH4 supplementation in a rodent DCM model. We observed a decreased BH4:total biopterin ratio in heart and mitochondria accompanied by cardiac remodeling, lower cardiac contractility, and mitochondrial dysfunction. Prolonged BH4 supplementation improved cardiac function, corrected morphological abnormalities in cardiac muscle, and increased mitochondrial activity. Proteomics analysis revealed oxidative phosphorylation (OXPHOS) as the BH4-targeted biological pathway in diabetic hearts as well as BH4-mediated rescue of down-regulated peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC-1α) signaling as a key modulator of OXPHOS and mitochondrial biogenesis. Mechanistically, BH4 bound to calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and activated downstream AMP-activated protein kinase/cAMP response element binding protein/PGC-1α signaling to rescue mitochondrial and cardiac dysfunction in DCM. These results suggest BH4 as a novel endogenous activator of CaMKK2.Keywords
Funding Information
- Ministry of Education (NRF-2020R1A4A1018943)
- Korea government (2018R1A2A3074998 and 2018R1D1A1A09081767)
This publication has 39 references indexed in Scilit:
- Human giant congenital melanocytic nevus exhibits potential proteomic alterations leading to melanotumorigenesisProteome Science, 2012
- Diabetic cardiomyopathy: pathophysiology and clinical featuresHeart Failure Reviews, 2012
- Angiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic CardiomyopathyJACC, 2012
- Mitochondrial dysfunction in diabetic cardiomyopathyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesisThe American Journal of Clinical Nutrition, 2011
- Cytoscape 2.8: new features for data integration and network visualizationBioinformatics, 2010
- Diabetic cardiomyopathy, causes and effectsReviews in Endocrine and Metabolic Disorders, 2010
- Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human HeartJACC, 2009
- In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase IDiabetes, 2009
- Tetrahydropteridine deficiency impairs mitochondrial function in Dictyostelium discoideum Ax2FEBS Letters, 2007